Abstract:Abstract Background Organ transplantation is predicted to increase as life expectancy and the incidence of chronic diseases rises. Regenerative medicine-inspired technologies challenge the efficacy of the current allograft transplantation model. Methods A literature review was conducted using the PubMed interface of MEDLINE from the National Library of Medicine. Results were examined for relevance to innovations of organ bioengineering to inform analysis of advances in regenerative medicine affecting organ transplantation. Data reports from the Scientific Registry of Transplant Recipient and Organ Procurement Transplantation Network from 2008 to 2019 of kidney, pancreas, liver, heart, lung and intestine transplants performed, and patients currently on waiting lists for respective organs, were reviewed to demonstrate the shortage and need for transplantable organs. Results Regenerative medicine technologies aim to repair and regenerate poorly functioning organs. One goal is to achieve an immunosuppression-free state to improve quality of life, reduce complications and toxicities, and eliminate the cost of lifelong antirejection therapy. Innovative strategies include decellularization to fabricate acellular scaffolds that will be used as a template for organ manufacturing, three-dimensional printing and interspecies blastocyst complementation. Induced pluripotent stem cells are an innovation in stem cell technology which mitigate both the ethical concerns associated with embryonic stem cells and the limitation of other progenitor cells, which lack pluripotency. Regenerative medicine technologies hold promise in a wide array of fields and applications, such as promoting regeneration of native cell lines, growth of new tissue or organs, modelling of disease states, and augmenting the viability of existing ex vivo transplanted organs. Conclusion The future of organ bioengineering relies on furthering understanding of organogenesis, in vivo regeneration, regenerative immunology and long-term monitoring of implanted bioengineered organs.

Transplantation: A Priority in the Healthcare Agenda

Organ donation and transplantation: a multi-stakeholder call to action

The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation

International issues in transplantation. Setting the scene and flagging the most urgent and controversial issues

Promoting Equitable and Affordable Patient Access to Safe and Effective Innovations in Donation and Transplantation of Substances of Human Origin and Derived Therapies

Donation and Equitable Access to Organ, Tissue, and Cell Transplants: A Brazilian Perspective on the Strategy and Plan of Action 2019-2030

Expanding Opportunities for Living Donation: Recommendations From the 2023 Santander Summit to Ensure Donor Protections, Informed Decision Making, and Equitable Access

Prevention of Trafficking in Organs, Tissues, and Cells

Developing and Expanding Deceased Organ Donation to Its Maximum Therapeutic Potential: An Actionable Global Challenge From the 2023 Santander Summit

Management of Patients Who Receive an Organ Transplant Abroad and Return Home for Follow-up Care: Recommendations From the Declaration of Istanbul Custodian Group

Organ procurement in Spain: Impact of transplant coordination

Transplantation in the Context of Migration and Refugees: A Summary of the DICG and TTS Ethics Committee Workshop, Buenos Aires, Argentina, September 2022

Regenerative medicine, organ bioengineering and transplantation

Ten Lessons From the Spanish Model of Organ Donation and Transplantation

Expanding the access to kidney transplantation: Strategies for kidney transplant programs

The future of Liver Transplantation

Current progress in xenotransplantation and organ bioengineering

Transplant and organ donation education: what matters?

Improvement in organ shortage through education

Santander Statement: Towards Global Convergence in Transplantation: Sufficiency, Transparency, and Oversight

Supporting Financial Neutrality in Donation of Organs, Cells, and Tissues